Related Experiment Video

Updated: Jun 13, 2026

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

Antibiotics for community-acquired pneumonia in children: is intravenous delivery necessary?

Anne H Thomson1

  • 1The John Radcliffe, Oxford Children's Hospital, Headington, Oxford OX9 3DU, UK. anne.thomson@orh.nhs.uk

Expert Review of Respiratory Medicine
|May 19, 2010
PubMed

Insights

Oral amoxicillin is equivalent to intravenous benzyl penicillin for treating childhood pneumonia. This approach shortens hospital stays for pediatric patients.

Area of Science:

  • Pediatric infectious diseases
  • Clinical pharmacology
  • Respiratory medicine

Background:

  • Community-acquired pneumonia (CAP) in children often leads to hospitalization and intravenous antibiotic treatment.
  • Oral antibiotics are effective against Streptococcus pneumoniae, a common CAP pathogen.
  • Previous research suggests good oral absorption of antibiotics in children.

Discussion:

  • The PIVOT trial is a multicenter, randomized controlled equivalence study.
  • It compared oral amoxicillin with intravenous benzyl penicillin for moderate/severe pediatric CAP.
  • The study focused on previously healthy children admitted to the hospital.

Key Insights:

  • Oral amoxicillin demonstrated equivalence to intravenous benzyl penicillin for treating pediatric CAP.
  • The oral antibiotic group experienced a significantly shorter duration of hospital stay.
  • This finding supports the use of oral antibiotics in hospitalized children with moderate/severe pneumonia.

Outlook:

  • Potential shift in treatment guidelines for pediatric CAP towards oral antibiotic administration.
  • Reduced healthcare costs and improved patient experience due to shorter hospitalizations.
  • Further research may explore cost-effectiveness and long-term outcomes of oral antibiotic therapy in pediatric CAP.

More Related Videos

A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii09:17

A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii

Published on: January 2, 2017

Related Concept Videos

Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...